Vicapsys Life Sciences
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Vicapsys Life Sciences generated cash of -$417,524, which is less than the previous year. Cash used in financing activities reached the amount of $412,849 last year. Net change in cash is therefore -$4,675.
Cash Flow
| 2017 | -3.16M | -41.17K | 3.68M |
|---|---|---|---|
| 2019 | -970.26K | 0 | 1.14M |
| 2020 | -262.89K | 0 | 0 |
| 2021 | -443.97K | 100K | 560K |
| 2022 | -238.19K | 0 | 34.99K |
| 2023 | -417.52K | 0 | 412.84K |
VICP Cash Flow Statement (2017 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2017 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 14.09K | 217.29K | 1.26K | 264.16K | 86.33K | 121.97K |
Operating activities | ||||||
Net income | -1.18M | -984.79K | -236.87K | -765.84K | -1.03M | -3.23M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 0 | 31.28K | 31.32K | 31.42K | 31.29K | 178.97K |
Stock-based compensation expense | 20.69K | 105.65K | 4.32K | 14.78K | 118.64K | 469.18K |
| Deferred income tax benefit | 20.69K | 105.65K | 4.32K | 14.78K | 118.64K | 469.18K |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 591.65K | 271.40K | -137.26K | 341.43K | 46.52K | -610.38K |
Cash generated by operating activities | -417.52K | -238.19K | -443.97K | -262.89K | -970.26K | -3.16M |
Investing activities | ||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 3 | -3 | 0 | 0 | 0 | -4.12K |
Acquisitions Net | 0 | 0 | 100K | 0 | 0 | 0 |
Cash generated by investing activities | 0 | 0 | 100K | 0 | 0 | -41.17K |
Financing activities | ||||||
Common Stock Issued | 100K | 34.99K | 560K | 0 | 971.5K | 3.68M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 262.40K | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 412.84K | 34.99K | 560K | 0 | 1.14M | 3.68M |
Net Change In Cash | -4.67K | -203.19K | 216.02K | -262.89K | 177.83K | 425.62K |
Cash at end of period | 9.42K | 14.09K | 217.29K | 1.26K | 264.16K | 547.59K |
| Data source | Data source | Data source | Data source |